glutathione nebulizer cystic fibrosis Pharmacologic Management of INHALATION THERAPY | METALAB
Description
Tingling sensation
10.3389/fonc.2017.00319 4
However, such studies have demonstrated that NAC and S-CMC reduced the exacerbation risk only in patients not treated with ICS, whereas erdosteine reduced COPD exacerbations irrespective of concomitant ICS use suggesting that erdosteine has additional pharmacological actions to ICS
Given their contribution to the maintenance of stem-like features of GIC, we first evaluated how these two pathways alone and their balance influence the expression of stem-like markers and self-renewal capacity
